Protein design aims to create customized antibodies for therapies, biosensors for diagnostics, or enzymes for chemical reactions.
Biogen nabs FDA approval for its biosimilar of arthritis and Covid-19 drug Actemra
Biogen scored an approval from the FDA for its biosimilar of Roche’s treatment Actemra on Friday, marking the first biosimilar of the drug to be